Dyadic appoints Joe Hazelton as President; strategic shift to ancillary proteins with commercial partnerships

DYADIC INTERNATIONAL INC

Hazelton promoted to President, continues as COO; base salary raised 10% to $320,000; 25,000-share option grant with 4-year vesting.
Strategic pivot to ancillary recombinant proteins for life sciences, nutrition, and industrial markets; validated by partnerships with Proliant Health, dairy enzyme firm, and EN3ZYME.
Legacy biopharma programs remain active under CEO Emalfarb; company to pursue corporate rebranding.
CEO states milestones validate strategy; Hazelton to scale commercialization and drive operational execution.

item 5.02 item 5.03 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Joseph Hazelton

President

DYAI · DYADIC INTERNATIONAL INC

Effective: 2025-05-29
Filed: June 2, 2025, 7:59 PM ET

On May 29, 2025, the board of directors (the "Board") of Dyadic International, Inc. (the "Company") appointed Joseph Hazelton as President of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Joseph Hazelton was appointed as President at DYADIC INTERNATIONAL INC.

Action: appointed
Role: President

Exact text from the filing

On May 29, 2025, the board of directors (the "Board") of Dyadic International, Inc. (the "Company") appointed Joseph Hazelton as President of the Company.

View on SEC.gov

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

DYADIC INTERNATIONAL INC: Amended and restated the Third Amended and Restated Bylaws to clarify election inspector roles, virtual meeting procedures, stockholder list provisions, and update officer and board committee meeting provisions (effective 2025-05-29).

Change: bylaw amendment
Effective: 2025-05-29

Exact text from the filing

On May 29, 2025, the Board amended and restated the Company’s Third Amended and Restated Bylaws (as amended and restated, the “Bylaws”), effective immediately.

View on SEC.gov

74 governance changes filed in the last 30 days. Browse all governance changes →

DYADIC INTERNATIONAL INC filing history →

Source: SEC EDGAR

accession 0001437749-25-019177

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.